GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » IntelliPharmaCeutics International Inc (OTCPK:IPCIF) » Definitions » Receivables Turnover

IntelliPharmaCeutics International (IntelliPharmaCeutics International) Receivables Turnover : 0.21 (As of Aug. 2023)


View and export this data going back to 1996. Start your Free Trial

What is IntelliPharmaCeutics International Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. IntelliPharmaCeutics International's Revenue for the three months ended in Aug. 2023 was $0.07 Mil. IntelliPharmaCeutics International's average Accounts Receivable for the three months ended in Aug. 2023 was $0.33 Mil. Hence, IntelliPharmaCeutics International's Receivables Turnover for the three months ended in Aug. 2023 was 0.21.


IntelliPharmaCeutics International Receivables Turnover Historical Data

The historical data trend for IntelliPharmaCeutics International's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IntelliPharmaCeutics International Receivables Turnover Chart

IntelliPharmaCeutics International Annual Data
Trend Nov13 Nov14 Nov15 Nov16 Nov17 Nov18 Nov19 Nov20 Nov21 Nov22
Receivables Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.69 16.74 11.54 - 66.00

IntelliPharmaCeutics International Quarterly Data
Nov18 Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23
Receivables Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 30.00 3.06 1.76 0.21

Competitive Comparison of IntelliPharmaCeutics International's Receivables Turnover

For the Biotechnology subindustry, IntelliPharmaCeutics International's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IntelliPharmaCeutics International's Receivables Turnover Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, IntelliPharmaCeutics International's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where IntelliPharmaCeutics International's Receivables Turnover falls into.



IntelliPharmaCeutics International Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

IntelliPharmaCeutics International's Receivables Turnover for the fiscal year that ended in Nov. 2022 is calculated as

Receivables Turnover (A: Nov. 2022 )
=Revenue / Average Total Inventories
=Revenue (A: Nov. 2022 ) / ((Accounts Receivable (A: Nov. 2021 ) + Accounts Receivable (A: Nov. 2022 )) / count )
=0.066 / ((0 + 0.001) / 1 )
=0.066 / 0.001
=66.00

IntelliPharmaCeutics International's Receivables Turnover for the quarter that ended in Aug. 2023 is calculated as

Receivables Turnover (Q: Aug. 2023 )
=Revenue / Average Total Inventories
=Revenue (Q: Aug. 2023 ) / ((Accounts Receivable (Q: May. 2023 ) + Accounts Receivable (Q: Aug. 2023 )) / count )
=0.069 / ((0.334 + 0) / 1 )
=0.069 / 0.334
=0.21

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


IntelliPharmaCeutics International  (OTCPK:IPCIF) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.


IntelliPharmaCeutics International Receivables Turnover Related Terms

Thank you for viewing the detailed overview of IntelliPharmaCeutics International's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


IntelliPharmaCeutics International (IntelliPharmaCeutics International) Business Description

Traded in Other Exchanges
Address
30 Worcester Road, Toronto, ON, CAN, M9W 5X2
IntelliPharmaCeutics International Inc is a pharmaceutical company. The company is engaged in the research, development, and manufacturing of novel and generic controlled-release and targeted-release oral solid dosage drugs. Its patented Hypermatrix technology is a multidimensional controlled-release drug delivery platform that can be applied to the development of a range of existing and new pharmaceuticals. Its ongoing drug development programs are at various stages of development in therapeutic areas that include neurology, cardiovascular, GIT, and pain. The company's product, a generic of Focalin XR, is partnered with Par Pharmaceutical, Inc. and received FDA approval. It derives revenue from the United States.

IntelliPharmaCeutics International (IntelliPharmaCeutics International) Headlines